Trade Bruker Corp - BRKR CFD

Bruker Company profile

About Bruker Corporation

Bruker Corporation is a developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. The Company operates through four segments: Bruker BioSpin Group, Bruker CALID Group, Bruker Scientific Instruments (BSI) Nano Group and Bruker Energy & Supercon Technologies (BEST). The Bruker BioSpin Group segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. The Bruker CALID Group segment designs, manufactures, and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments, and solutions. The BSI NANO Group segment designs and manufactures advanced X-ray instruments; advanced fluorescence optical microscopy instruments; analytical tools for electron microscopes and X-ray metrology; and defect-detection equipment. The BEST segment develops and manufactures superconducting and non-superconducting materials and devices.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Bruker Corporation revenues increased 22% to $2.42B. Net income increased 76% to $277.1M. Revenues reflect BSI Life Science segment increase of 20% to $1.51B, BSI NANO segment increase of 25% to $697.5M, Bruker Energy & Supercon Technologies segment increase of 18% to $223.8M, United States segment increase of 32% to $601M, Europe segment increase of 27% to $658.1M.

Equity composition

Common Stock $.01 Par, 12/11, 260M auth., 165,892,170 issd., less 20,265 shs. in Treas. @ $200K. Insiders control 51.53%. 7/03, Company formed through a merger of common control between Bruker AXS and Bruker Daltonics; 02/08, Name changed from Bruker BioSciences Corp.